Winton Group LTD Viatris Inc Transaction History

Winton Group LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$9.2 - $12.26 $744,206 - $991,735	-80,892 Reduced 59.8%	54,368 $523,000
Q4 2022 Feb 14, 2023	BUY	$8.72 - $11.56 $989,676 - $1.31 Million	113,495 Added 521.46%	135,260 $1.51 Million
Q3 2022 Nov 10, 2022	SELL	$8.48 - $11.13 $1.37 Million - $1.8 Million	-161,324 Reduced 88.11%	21,765 $185,000
Q2 2022 Aug 10, 2022	BUY	$9.95 - $12.27 $1.35 Million - $1.67 Million	135,981 Added 288.66%	183,089 $1.92 Million
Q1 2022 May 11, 2022	BUY	$9.81 - $15.4 $462,129 - $725,463	47,108 New	47,108 $513,000
Q4 2021 Feb 10, 2022	SELL	$12.09 - $14.68 $1.26 Million - $1.52 Million	-103,850 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$13.25 - $15.13 $167,413 - $191,167	12,635 Added 13.85%	103,850 $1.41 Million
Q2 2021 Aug 10, 2021	BUY	$12.97 - $16.15 $1.18 Million - $1.47 Million	91,215 New	91,215 $1.3 Million

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.